Most brands returned to the same conceptual wells while emergent ad categories like AI and health and wellness offered a mixed bag.
Union Home Minister and Minister of Cooperation, Amit Shah will deliver keynote address at National Conference on "Tackling ...
Presented by the Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care The Big Story Legal pressures ...
The Trump administration could take action including an injunction or fines against online telehealth company Hims for intending to sell a compounded version of Novo Nordisk's Wegovy weight-loss pill, ...
Hims & Hers (HIMS) stock falls as Novo Nordisk (NVO) sues the firm over a key patent related to its weight loss therapy ...
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...
A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.
Hims & Hers caused a firestorm last week when it revealed that it planned to launch a knockoff version of Novo Nordisk's new ...
The Super Bowl ad by Hims & Hers sparked controversy over its cancer detection test, raising questions about its accuracy.
Novo Nordisk A/S said it’s suing Hims & Hers Health Inc. for making knock-offs of its obesity medicines, even as Hims scrapped plans to sell a copycat version of the Wegovy pill.
Hims & Hers scraps low-cost weight-loss pill following backlash Him & Hers (NYSE:HIMS) shares are set to open 23% lower at ...
Stocktwits on MSN
Novo Nordisk sues Hims & Hers over compounded Wegovy, calls for permanent sales ban: HIMS stock tanks
Novo also stated that Hims & Hers is duping consumers and healthcare professionals as to the clinical benefits and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results